Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies

Diagnostic Pathology

Volumn 6, Issue SUPPL. 1, 2011, Pages

  Fasanella, S ^a   Leonardi, E ^a   Cantaloni, C ^a   Eccher, C ^b   Bazzanella, I ^a   Aldovini, D ^a   Bragantini, E ^a   Morelli, L ^a   Cuorvo, L V ^a   Ferro, A ^a   Gasperetti, F ^a   Berlanda, G ^a   Dalla Palma, P ^a   Barbareschi, M ^a  

^a SANTA CHIARA HOSPITAL   (Italy)

^b FONDAZIONE BRUNO KESSLER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; KI 67 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BREAST TUMOR; CELL PROLIFERATION; CHEMISTRY; COMPUTER ASSISTED DIAGNOSIS; FEASIBILITY STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL PROLIFERATION; FEASIBILITY STUDIES; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; OBSERVER VARIATION;

EID: 79953143904     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-6-S1-S7     Document Type: Article

References (17)

1. Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983, 31:13-20. 10.1002/ijc.2910310104, 6339421.
2. Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984, 133:1710-1715.
3. Bouzubar N, Walker KJ, Griffiths K, et al. Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer 1989, 59:943-947. 10.1038/bjc.1989.200, 2246720, 2472168.
4. Goldhirsch A, Ingle JN, Gelber RD, et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol 2009, 20:1319-1329. 10.1093/annonc/mdp322, 2720818, 19535820.
5. Jung SY, Han W, Lee JW, et al. Ki-67 expression gives additional prognostic information on St. Gallen 2007 and Adjuvant! Online risk categories in early breast cancer. Ann Surg Oncol 2009, 16:1112-1121. 10.1245/s10434-009-0334-7, 19219507.
6. Viale G, Regan MM, Mastropasqua MG, et al. Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Natl Cancer Inst 2008, 100:207-212. 10.1093/jnci/djm289, 18230798.
7. Yerushalmi R, Woods R, Ravdin PM, et al. Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol 2010, 11:174-183. 10.1016/S1470-2045(09)70262-1, 20152769.
8. Stuart-Harris R, Caldas C, Pinder SE, et al. Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast 2008, 17:323-334. 10.1016/j.breast.2008.02.002, 18455396.
9. Offersen BV, Sorensen FB, Knoop A, et al. The prognostic relevance of estimates of proliferative activity in early breast cancer. Histopathology 2003, 43:573-582. 10.1111/j.1365-2559.2003.01745.x, 14636258.
10. Demichelis F, Barbareschi M, Dalla PP, et al. The virtual case: a new method to completely digitize cytological and histological slides. Virchows Arch 2002, 441:159-164. 10.1007/s00428-001-0561-1, 12189506.
11. Barbareschi M, Girlando S, Mauri FM, et al. Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas. Am J Clin Pathol 1994, 102:171-175.
12. Bevilacqua P, Verderio P, Barbareschi M, et al. Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma. Breast Cancer Res Treat 1996, 37:123-133. 10.1007/BF01806494, 8750580.
13. Lindboe CF, von der OG, Torp SH. Determination of proliferation index in neoplasms using different Ki-67 equivalent antibodies. APMIS 2003, 111:567-570. 10.1034/j.1600-0463.2003.1110505.x, 12887508.
14. Lindboe CF, Torp SH. Comparison of Ki-67 equivalent antibodies. J Clin Pathol 2002, 55:467-471. 1769671, 12037032.
15. Torp SH, Johannesen E, Lindboe CF. Comparison of different Ki67 antibodies in human glioblastomas. Clin Mol Pathol 1995, 48:M191-M193. 10.1136/mp.48.4.M191, 407960, 16696004.
16. Vilches-Moure JG, Ramos-Vara JA. Comparison of rabbit monoclonal and mouse monoclonal antibodies in immunohistochemistry in canine tissues. J Vet Diagn Invest 2005, 17:346-350.
17. Rossi S, Laurino L, Furlanetto A, et al. Rabbit monoclonal antibodies: a comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies. Am J Clin Pathol 2005, 124:295-302. 10.1309/NR8HN08GDPVEMU08, 16040303.